We are excited to announce that Zelmic will be exhibiting at this year’s NLSdays (Nordic Life Science Days) in Malmö! As one of the leading events in the Nordic region, NLSdays brings together key players in the life science sector, and we’re thrilled to be a part of it again this year. Visit Us at…
Read moreCenter for Translational Research AB (CTR) expands by acquiring Zelmic AB, the GMP-approved Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), specialized in development of topical and transdermal pharmaceutical formulations and drug delivery. The acquisition further expands CTRs portfolio, within pharmaceutical, regulatory, and clinical development to the CTR group.
Read moreSeptember 7th at the Medicon Village in Lund Zelmic will participate at The Future of Swedish & Danish Life Scence held at Medicon Village (Restaurant & Café Inspira). See you there!
Read moreSeptember 6th in Copenhagen Zelmic will participate at the event New Updates in Drug Formulation & Bioavailabilityheld at Medicon Valley Alliance headquarters in Copenhagen on September 6th 2023. See you there!
Read moreHighlighting the latest trends, accomplishments, and innovations in the field of topical development for Zelmic:
Read moreAs we move into the new year, I wanted to take a moment to update you on the exciting developments happening at our organization.
Read moreZelmic will participate at CPHI Frankfurt on November 1-3, 2022 David Sagna is excited to meet new clients and suppliers to discuss topical drug development and the opportunities with the new IMP topical manufacturing unit. This trip was facilitated in connection with the EU.
Read more